SF

Samreen Fatima

Active Director Director DIN 11067317
DIN 11067317 First appointment Apr 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Apr 2025
Shareholding value Locked Premium profile

About Samreen Fatima

Samreen Fatima has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Lylix Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 11067317
Primary Designation Director
First Appointment 21 Apr 2025
Oldest Company Age 1 yrs

Current companies

Company Designation Appointment Founded Status
Lylix Biotech Private Limited U46497UP2025PTC221908
Director 21 Apr 2025 2025 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lylix Biotech Private Limited
Premium access

Shareholding and investment profile for Samreen Fatima

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Samreen Fatima

Samreen Fatima has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Lylix Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Samreen Fatima is associated with 1 company as Director.

Samreen Fatima has expertise in Technology.

Samreen Fatima has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available